Ms Megan Kentish
Program Director & Physiotherapist, Queensland Paediatric Rehabilitation Service
Children's Health Queensland
Journal Articles
Armstrong, Ellen L., Boyd, Roslyn N., Horan, Sean A., Kentish, Megan J., Ware, Robert S. and Carty, Christopher P. (2022). Maintenance of Functional Gains Following a Goal-Directed and FES-Assisted Cycling Program for Children With Cerebral Palsy. Pediatric Physical Therapy, 34 (4), 480-487. doi: 10.1097/pep.0000000000000942
Gibson, Noula, Wynter, Meredith, Thomason, Pam, Baker, Felicity, Burnett, Heather, Graham, H. Kerr, Kentish, Megan, Love, Sarah C., Maloney, Eliza, Stannage, Katherine and Willoughby, Kate (2022). Australian hip surveillance guidelines at 10 years: new evidence and implementation. Journal of Pediatric Rehabilitation Medicine, 15 (1), 31-37. doi: 10.3233/PRM-220017
Armstrong, Ellen L., Boyd, Roslyn N., Horan, Sean A., Kentish, Megan J., Ware, Robert S and Carty, Christopher P (2020). Functional electrical stimulation cycling, goal‐directed training, and adapted cycling for children with cerebral palsy: a randomized controlled trial. Developmental Medicine and Child Neurology, 62 (12) dmcn.14648, 1406-1413. doi: 10.1111/dmcn.14648
Armstrong, Ellen L., Spencer, Sian, Kentish, Megan J., Horan, Sean A., Carty, Christopher P. and Boyd, Roslyn N. (2019). Efficacy of cycling interventions to improve function in children and adolescents with cerebral palsy: a systematic review and meta-analysis. Clinical Rehabilitation, 33 (7), 1113-1129. doi: 10.1177/0269215519837582
Thomas, Rachel E., Johnston, Leanne M., Sakzewski, Leanne, Kentish, Megan J. and Boyd, Roslyn N. (2016). Evaluation of group versus individual physiotherapy following lower limb intra-muscular Botulinum Toxin-Type A injections for ambulant children with cerebral palsy: a single-blind randomized comparison trial. Research in Developmental Disabilities, 53-54, 267-278. doi: 10.1016/j.ridd.2016.02.014
Edwards, Priya, Sakzewski, Leanne, Copeland, Lisa, Gascoigne-Pees, Laura, McLennan, Kim, Thorley, Megan, Kentish, Megan, Ware, Robert and Boyd, Roslyn (2015). Safety of botulinum toxin type a for children with nonambulatory cerebral palsy. Pediatrics, 136 (5), 895-904. doi: 10.1542/peds.2015-0749
Copeland, Lisa, Edwards, Priya, Thorley, Megan, Donaghey, Samantha, Gascoigne-Pees, Laura, Kentish, Megan, Lindsley, Jayne, McLennan, Kim, Sakzewski, Leanne and Boyd, Roslyn N. (2014). Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial. Journal of Pediatrics, 165 (1), 1-11. doi: 10.1016/j.jpeds.2014.01.050
Thorley, Megan, Donaghey, Samantha, Edwards, Priya, Copeland, Lisa, Kentish, Megan, McLennan, Kim, Lindsley, Jayne, Gascoigne-Pees, Laura, Sakzewski, Leanne and Boyd, Roslyn N. (2012). Evaluation of the effects of Botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: A double blind randomized controlled trial. BMC Pediatrics, 12 (1) 120, 120.1-120.23. doi: 10.1186/1471-2431-12-120
Kentish, M., Wynter, M., Snape, N. and Boyd, R. (2011). Five-year outcome of state-wide hip surveillance of children and adolescents with cerebral palsy. Journal of Pediatric Rehabilitation Medicine, 4 (3), 205-217. doi: 10.3233/PRM-2011-0176
Conference Papers
Luke, Carly, Mick-Ramsamy, Leeann, Benfer, Katherine, Ware, Robert S., Leishman, Shaneen, Bosanquet, Margot, Gordon, Anya, Williams, Hailey, Taifalos, Chloe, Oakes, Ellena, Smith, Maria, Kentish, Megan, McNamara, Lynda, Bos, Arend F. and Boyd, Roslyn N. (2024). Early screening tools predict neurodevelopmental outcomes at 12 months in a developmentally vulnerable First Nations infant cohort. American Academy of Cerebral Palsy and Developmental Medicine, Quebec, QC, Canada, 23-26 October 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.
Luke, Carly, McNamara, Lynda, Carlton, Morgan, Finn, Christine, Gibson, Sarah, Morris, Kym, Shannon, Bernadette, Oakes, Ellena, Gordon, Anya, Thomas, Rachel, George, Joanne, Kentish, Megan, Ware, Robert S. and Boyd, Roslyn N. (2023). Prediction of adverse Neurodevelopmental Outcomes in a state-wide Early Detection Network (QEDIN-CP). American Academy of Cerebral Palsy and Developmental Medicine, Chicago, IL, United States, 10-13 September 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.
Thomas, R., Johnston, L. M., Sakzewski, L., Case, V. and Kentish, M. (2012). GRIN: randomised trial of group versus individual models of physiotherapy for ambulant children with cerebral palsy following lower limb Botulinum Toxin-A. 6th Biennial Conference of the Australasian Academy of Cerebral Palsy and Developmental Medicine, Brisbane, Australia, 30 May - 2 June 2012. Oxford, United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1469-8749.2012.04289.x
Copeland, L., Thorley, M., Edwards, P., Donaghey, S., Kentish, M., McLennan, K., Sakzewski, L. and Boyd, R. N. (2012). Double blind randomized trial of Botulinum Toxin-A and therapy compared to sham and therapy for care and comfort goals in children with marked cerebral palsy. 6th Biennial Conference of the Australasian Academy of Cerebral Palsy and Developmental Medicine, Brisbane, QLD Australia, 30 May - 2 June 2012. Oxford, United Kingdom: Wiley-Blackwell. doi: 10.1111/j.1469-8749.2012.04289.x